These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7237449)

  • 1. Plasma levels and urinary excretion of methyl-GAG following iv infusion in man.
    Marsh KC; Liesmann J; Patton TF; Fabian CJ; Sternson LA
    Cancer Treat Rep; 1981; 65(3-4):253-7. PubMed ID: 7237449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialyzability of methyl-GAG.
    Jensen B; Williams RD; Ohnuma T; Roboz J
    Cancer Treat Rep; 1983 Mar; 67(3):283-4. PubMed ID: 6831474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of IMPY by radioimmunoassay.
    Fong KL; Ho DH; Yap BS; Stewart D; Brown NS; Benjamin RS; Freireich EJ; Bodey GP
    Cancer Treat Rep; 1980; 64(12):1253-60. PubMed ID: 7471115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancer.
    Child JA; Bono AV; Fossa SD; Ten Bokkel Huinink WW; De Pauw M; Stoter G
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):85-7. PubMed ID: 7200896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
    Yap HY; Blumenschein GR; Schell F; Bodey GP
    Cancer Treat Rep; 1981; 65(5-6):465-7. PubMed ID: 7237467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some aspects of clearance of mitoguazone in cancer patients and experimental cancer models.
    Dunzendorfer U; Balis ME; Whitmore WF
    Arzneimittelforschung; 1986 Mar; 36(3):506-8. PubMed ID: 3518731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
    Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of Methyl-GAG on a transplantable murine renal cell adenocarcinoma.
    Williams PD; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):153-61. PubMed ID: 6844733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of teniposide in patients with ovarian cancer.
    D'Incalci M; Rossi C; Sessa C; Urso R; Zucchetti M; Farina P; Mangioni C
    Cancer Treat Rep; 1985 Jan; 69(1):73-7. PubMed ID: 3967261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.
    Chen HX; Marshall JL; Ness E; Martin RR; Dvorchik B; Rizvi N; Marquis J; McKinlay M; Dahut W; Hawkins MJ
    Clin Cancer Res; 2000 Apr; 6(4):1259-66. PubMed ID: 10778949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP
    Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
    [No Abstract]   [Full Text] [Related]  

  • 12. Methyl-GAG in advanced renal cell carcinoma.
    Child JA
    Prog Clin Biol Res; 1982; 100():663-7. PubMed ID: 7145994
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation.
    Pinguet F; Martel P; Fabbro M; Petit I; Canal P; Culine S; Astre C; Bressolle F
    Anticancer Res; 1997; 17(1B):605-11. PubMed ID: 9066587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
    Chen TL; Passos-Coelho JL; Noe DA; Kennedy MJ; Black KC; Colvin OM; Grochow LB
    Cancer Res; 1995 Feb; 55(4):810-6. PubMed ID: 7850794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of methyl-GAG in advanced renal cancer.
    Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
    Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
    [No Abstract]   [Full Text] [Related]  

  • 16. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.
    Tetef ML; Synold TW; Chow W; Leong L; Margolin K; Morgan R; Raschko J; Shibata S; Somlo G; Yen Y; Groshen S; Johnson K; Lenz HJ; Gandara D; Doroshow JH
    Clin Cancer Res; 2001 Jun; 7(6):1569-76. PubMed ID: 11410492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study.
    Stathopoulos GP; Boulikas T; Vougiouka M; Deliconstantinos G; Rigatos S; Darli E; Viliotou V; Stathopoulos JG
    Oncol Rep; 2005 Apr; 13(4):589-95. PubMed ID: 15756428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.